China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'To evaluate the efficacy and safety of a serum product in improving facial SL/SK and post-inflammatory hyperpigmentation in adult females'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130270
Registration Time: 2026/08/18
Type: Interventional study
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=321249
Published by HT Digital Content Services with permission from Health Daily Digest....